Skip to main content
. 2021 Oct 28;12:730045. doi: 10.3389/fmicb.2021.730045

TABLE 1.

Primary sequence and secondary structure elements analysis of the JEV’s UTRs.

UTR 5′UTR
3′UTR
Genotypes I II III IV V I II III IV V
Primary sequence Length (nt) 96 95 95 95 95 565–571 570 557–583 584 586–591
Similarity 90.7–100%
(μ = 98.31%)
95.9–100%
(μ = 99.36%)
99–100%
(μ = 99.34%)
95.5–100%
(μ = 98.71%)
88.6–100%
(μ = 97.83%)
94.9–100%
(μ = 96.6%)
Nucleotide composition A = 32.38% A = 31.58% A = 31.58% A = 29.47% A = 32.63% A = 28.12% A = 29.3% A = 29.17% A = 29.28% A = 30.72%
G = 24.00% G = 24.21% G = 24.20% G = 24.21% G = 24.21% G = 29.65% G = 28.95% G = 29.03% G = 28.42% G = 28.51%
T = 31.14% T = 32.63% T = 32.66% T = 33.68% T = 31.93% T = 18.32% T = 18.25% T = 18.51% T = 18.15% T = 18.83%
C = 12.50% C = 11.58% C = 11.57% C = 12.63% C = 11.23% C = 23.92% C = 23.51% C = 23.42% C = 24.14% C = 21.95%
A > T > G > C T > A > G > C T > A > G > C T > A > G > C A > T > G > C G > A > C > T A > G > C > T A > G > C > T A > G > C > T A > G > C > T
Repeat sequences (number) 5 4 4 3 4 5 4 5 5 4

Secondary structure (Location and length) SLA 5–71
(67 nt)
5–71
(67 nt)
5–71
(67 nt)
11–73
(63 nt)
5–71
(67 nt)
na na na na na
SLB 73–109
(37 nt)
73–108
(36 nt)
73–108
(36 nt)
85–95
(11 nt)
73–108
(36 nt)
na na na na na
5′UAR| 79–103
(13 nt)
79–102
(14 nt)
79–102
(15 nt)
79–102
(13 nt)
79–102
(12 nt)
na na na na na
UFS| | 73–109
(12 nt)
73–108
(12 nt)
73–108
(12 nt)
73–108
(12 nt)
na na na na na
cHP 116–135
(20 nt)
115–134
(20 nt)
115–134
(20 nt)
115–134
(20 nt)
115–134
(20 nt)
na na na na na
5′DAR 109–113
(5 nt)
108–112
(5 nt)
108–112
(5 nt)
108–112
(5 nt)
108–112
(5 nt)
na na na na na
5′cCS 137–147
(11 nt)
136–146
(11 nt)
136–146
(11 nt)
136–146
(11 nt)
136–146
(11 nt)
na na na na na
Domain1 VVR na na na na na 1–48
(48 nt)
1–49
(49 nt)
1–62
(62 nt)
1–62
(62 nt)
1–74
(74 nt)
xrRNA1 na na na na na 54–128
(75 nt)
55–129
(75 nt)
68–142
(75 nt)
68–142
(75 nt)
80–154
(75 nt)
3′vrSL na na na na na 136–208
(73 nt)
137–209
(73nt)
150–222
(73 nt)
150–222
(73 nt)
162–234
(73 nt)
xrRNA2 na na na na na 123–278
(67 nt)
214–280
(67 nt)
227–293
(67 nt)
228–293
(66 nt)
238–302
(65 nt)
PK1| na na na na na 83–87 107–111 (3 nt) 84–88 108–112 (3 nt) 97–101 121–125 (3 nt) 97–101 121–125 (3 nt) 109–113 133–137 (3 nt)
PK2 na na na na na 240–242 261–263 (3 nt) 241–243 262–264 (3 nt) 254–256 275–277 (3nt) 254–256 275–277 (3 nt) 263–265 284–286 (3 nt)
3′vrCS1 na na na na na 154–179 (26 nt) 155–180 (26 nt) 168–193 (26 nt) 168–193 (26 nt) 180–205 (26 nt)
Domain2 DB1 na na na na na 300–370 (71 nt) 301–371 (71 nt) 314–384 (71 nt) 314–384 (71 nt) 323–393 (71 nt)
DB2 na na na na na 381–448 (68 nt) 382–449 (68 nt) 395–462 (68 nt) 395–462 (68 nt) 402–469 (68 nt)
PK3 na na na na na 322–328 449–455 (7 nt) 323–329 450–456 (7 nt) 336–342 463–469 (7 nt) 336–342 463–469 (7 nt) 345–351 450–456 (7 nt)
PK4 na na na na na 403–407 459–463 (5 nt) 404–408 459–463 (5 nt) 417–421 472–475 (5 nt) 417–421 472–476 (5 nt) 424–428 480–484 (5 nt)

3′dbRCS na na na na na 341–367 419–445 (27 nt) 342–368 420–446 (27 nt) 355–381 433–459 (27 nt) 355–381 433–459 (27 nt) 364–390 440–466 (27 nt)
3′dbCS2 na na na na na 381–391 (11 nt) 382–392 (11 nt) 395–405 (11 nt) 395–405 (11 nt) 402–412 (11 nt)
3′dbsHP na na na na na 450–464 (15nt) 451–464 (14 nt) 464–477 (14 nt) 464–477 (14 nt) 471–485 (15 nt)
3′cCS na na na na na 460–470 (11 nt) 460–470 (11 nt) 473–483 (11 nt) 473–483 (11 nt) 481–491 (11 nt)
3′sHP na na na na na 473–489 (17 nt) 473–489 (17 nt) 486–502 (17 nt) 486–502 (17 nt) 494–510 (17 nt)
3′DAR na na na na na 473–478 (5 nt) 473–478 (5 nt) 486–491 (5 nt) 486–491 (5 nt) 494–498 (5 nt)
3′UAR| na na na na na 481–504 (13 nt) 481–504 (14 nt) 495–417 (15 nt) 495–417 (13 nt) 502–525 (12 nt)
3′SL na na na na na 490–573 (84 nt) 490–573 (84 nt) 503–586 (84 nt) 503–586 (85 nt) 511–594 (84 nt)

| : Non-contiguous nucleic acid sequence; | | : non-contiguous complementary nucleic acid sequence; NA: Not available. The results of nucleotide similarity and base composition were all within genotypes. SLA, stem loop A; SLB, stem loop B; UFS, 5′-UAR-flanking stem; 5′UAR, 5′ upstream AUG region; 5′DAR, 5′ downstream AUG region; cHP, capsid-coding region hairpin; 5′cCS, 5′cyclization sequence; VR, variable region; xrRNA, the exoribonuclease XRN1 resistant RNA; PK, pseudoknot; 3′vrCS1, the 3′UTR variable region conserved sequences 1; 3′dbRCS, the 3′UTR dumbbell structure repeated conserved sequences; 3′dbCS2, the 3′UTR dumbbell structure conserved sequences 2; 3′dbsHP, the 3′UTR DB region small hairpin; 3′cCS, 3′cyclization sequence; 3′DAR, 3′ downstream AUG region; 3′UAR, 3′upstream AUG region upstream AUG region; 3′sHP, the 3′UTR short hairpin; 3′SL, the 3′UTR stem loop.